Remdesivir has very little effect on Covid-19 mortality, WHO finds
by Sarah Boseley Health editor from on (#595SS)
Results of major trial described as sobering, with drug found not to improve survival rates
Remdesivir, one of the big treatment hopes for Covid-19, has very little effect on preventing deaths, according to a large and comprehensive trial run by the World Health Organization.
The drug, made by the US biotech firm Gilead, has been talked up as a potential cure and was taken by Donald Trump. A trial in the US had previously showed it reduced the length of stay in hospital. But the gold-standard Solidarity WHO trial, which was based on a far larger sample - 3,000 people on the drug, compared with as many who were not - showed remdesivir had little effect on deaths over 28 days.
Continue reading...